Navigation Links
Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
Date:6/17/2013

mmended in hepatic impairment and is contraindicated in renal impairment. Ensure normal renal function before initiating and at least annually thereafter. Temporarily discontinue in patients undergoing radiologic studies with intravascular iodinated contrast materials or any surgical procedures necessitating restricted intake of food and fluids. Lactic acidosis due to metformin accumulation during therapy is fatal in approximately 50% of cases. The risk increases in patients with renal impairment, congestive heart failure requiring drug treatment, and with increasing age.

Vitamin B12 deficiency: Metformin may lower Vitamin B12 levels. Monitor hematologic parameters annually.

Warnings and Precautions—for OSENI

Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure. Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk. Monitor patients for signs and symptoms.

Edema: Dose-related edema may occur. Use with caution in patients with edema.

Fractures: Increased incidence in female patients. Apply current standards of care for assessing and maintaining bone health.

Bladder cancer: Data suggest an increased risk of bladder cancer in pioglitazone users. Data also suggest that the risk increases with duration of use. Do not use OSENI in patients with active bladder cancer. Use caution when using in patients with a prior history of bladder cancer. Tell patients to promptly report any sign of hematuria or other symptoms such as dysuria or urinary urgency as these may be due to bladder cancer.

Macular edema: Macular edema has been reported in some patients taking pioglitazone. Recommend regular eye exams. Instruct patients to report any visual changes promptly.

Ovulation: Therapy with pioglitazone may result in ovulation in some premenopausal anovulatory women.

Warnings and Precautions—for NESINA, KAZANO,
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014  Proteomics is ... to a new report from Kalorama Information.  The healthcare ... had occurred in proteomics in the past two ... to agreements between private proteomic companies and academic ... with novel proteomics innovator companies.  Kalorama observed the ...
(Date:9/30/2014)... , 30. September 2014 ... http://photos.prnewswire.com/prnh/20130430/LA01948LOGO Acutus ... ein minimal-invasives 3D-Herzkammer-Bildgebungs- und Dipoldichte-Mappingsystem in ... die zu komplexen Herzrhythmusstörungen einschließlich Vorhofflimmern ... Abschluss einer zusätzlichen Finanzierung über 26,2 ...
(Date:9/30/2014)... , Sept. 30, 2014 One week after ... major milestone: Alzheimer,s Team reaches over 200,000 ... and caregivers, was developed to draw attention to clinical ... disease. It also provides inspirational support and fosters online ... as the leading healthcare concern for people over the ...
Breaking Medicine Technology:Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 2MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 4
... 27, 2011 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin ... developer, manufacturer and seller of medicine and drugs in ... in response to recent investor interest, the Company has ... Qi local government and wishes to provide additional details ...
... Fla., Jan. 27, 2011 Lakewood-Amedex Inc., a leading ... United States Patent and Trademark Office has issued Notice ... use of novel monoclonal antibodies for the treatment of ... secreting E.coli O157: H7 strain. ...
Cached Medicine Technology:Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government 2Lakewood-Amedex Inc. Receives Notice of Allowance on Three US Patent Applications Relating to Treatment of Hemolytic Uremic Syndrome 2Lakewood-Amedex Inc. Receives Notice of Allowance on Three US Patent Applications Relating to Treatment of Hemolytic Uremic Syndrome 3
(Date:9/30/2014)... (PRWEB) September 30, 2014 Fat Burning ... specialist and best-selling author Mike Geary that is helping people ... their body into a fat-burning machine in less than 24 ... investigative review. , “In our culture that is becoming ... hard to decipher what is really fact and fiction when ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 VisitandCare.com ... in Turkey has gone up more than 79 percent ... medical tourism company also reported total revenue tripled for ... , The company’s professional strategy has allowed them to ... ultimately designed for patient comfort and privacy — with ...
(Date:9/30/2014)... With the flu season upon ... day, it’s a perfect time to announce Jan-Pro’s ... is an electro-static disinfectant delivery system that dries ... missed with spray-on disinfectant applicators. , The EnviroShield ... electrostatic negative charge to the disinfecting solution. ...
(Date:9/30/2014)... 30, 2014 Dr. Karl R.O.S. Johnson, ... program of care that is dramatically improving the ... clinic—Johnson Chiropractic Neurology & Nutrition—applies a proprietary, multi-dimensional approach ... also addresses sources of inflammation, neurology of the joint ... chain” from the brain to the spine, to the ...
(Date:9/30/2014)... 30, 2014 (HealthDay News) -- Medicare should cover low-dose ... risk for the disease, a coalition of more than ... which includes the Lung Cancer Alliance, the Society of ... Cancer Society and the American Society of Clinical Oncology, ... the U.S. Centers for Medicare & Medicaid Services (CMS). ...
Breaking Medicine News(10 mins):Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2
... be attributed to Jeff Smith, DVM, president, ... California Veterinary Medical Association:, SACRAMENTO, Calif., Oct. 15 ... a disappointment. The decision,of the Court of Appeals -- which ... the delivery of veterinary services in,California. The regulatory authority of ...
... the knowledge and treatment of schizophrenia, depression, ... Oct. 15 Five of the most prestigious ... of great,achievement by NARSAD, the world,s leading charity ... here this Friday at the,Waldorf-Astoria Hotel. Because ...
... for patients, researchers say , , MONDAY, Oct. 15 ... find nicotine patches or hot pepper-based chemicals on ... patches and the hot pepper-derivative capsaicin both provided ... presented at the American Society of Anesthesiologists, annual ...
... as a pivotal tumor suppressor for both human and mouse ... The research, published by Cell Press in the October 2007 ... of new drug therapies for lung cancer. , Lung cancer ... responsible for 1.3 million deaths each year. Non-small-cell lung cancers ...
... ALBUQUERQUE, N.M., Oct. 15 Two clinical,research scientists ... ( http://www.biomoda.com ) of Albuquerque, NM, to assist ... detection,testing and other cancer diagnostic technology. "Constance ... diagnostic products development and FDA regulations to,Biomoda. She ...
... 15 HMS Holdings Corp. (Nasdaq:,HMSY) today announced it will host a webcast ... the financial results for the,third quarter 2007, which ended September 30. Financial results ... Robert Holster, Chairman and CEO, WHEN: ... 10:00 AM ET, HOW: Presentation: ...
Cached Medicine News:Health News:California Veterinary Medical Association Reacts to Supreme Court Decision 2Health News:NARSAD - the World's Leading Mental Health Research Charity - Presents 2007 Prizes for Outstanding Psychiatric Research at New York Gala, October 19th 2Health News:NARSAD - the World's Leading Mental Health Research Charity - Presents 2007 Prizes for Outstanding Psychiatric Research at New York Gala, October 19th 3Health News:Nicotine, Chili Peppers Offer Post-Surgery Pain Relief 2Health News:Nicotine, Chili Peppers Offer Post-Surgery Pain Relief 3Health News:DMP1 deletion cooperates with oncogenic K-ras in lung cancer 2Health News:Two Scientists Join Team of Biomoda, Inc. 2Health News:HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation 2
... Access ...unlike any trocar system you've ever ... actually four systems in one designed ... adaptive to all of your needs., ... or dilating tip styles, OnePort™ can effectively ...
... complete line of Surgical Access ...unlike any ... OnePort™ trocar system is actually four systems ... operationally flexible and clinically adaptive to all ... in disposability and bladed or dilating tip ...
... FPK01 Thoracic Trocar Pak ... 15mm flexible sleeves and (1) ... ,FPK02 Thoracic Trocar Pak ... 15mm flexible sleeves., ,FPK03 ...
... FLEXIPATH Flexible Surgical Thoracic Trocar ... mechanical obturator and a flexible ... prevent puncture or laceration to ... has securing holes to secure ...
Medicine Products: